��rst critical step
toward re-examining the evaluation and treatment of
patients with a spectrum of lower extremity arterial disease.
It is intended to be an iterative process with the goal of
more precisely stratifying patients according to their initial
disease burden, analogous to TNM cancer staging, but not
to dictate therapy.
One important potential application of this system is
for improved clinical trials design. Appropriate stratiﬁcation

JOURNAL OF VASCULAR SURGER